These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2444083)

  • 21. [Cisplatin, methotrexate and peplomycin in the treatment of esophageal carcinoma].
    Kagami Y; Sakurai T; Nishio M; Narimatsu N; Saitoh A; Koshiba R; Ikeda H
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3523-6. PubMed ID: 2431655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
    J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
    Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
    Takeuchi S; Yamada T; Sekine H; Katoh M; Washizuka M; Fukui I; Yokokawa M
    Hinyokika Kiyo; 1984 Nov; 30(11):1619-25. PubMed ID: 6084949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
    Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy].
    Momose H; Arai K; Nakagawa Y; Fujimoto K; Tsujimoto S; Cho M; Tani Y; Saka M; Nakatsuji F; Iwai A
    Hinyokika Kiyo; 1989 May; 35(5):781-8. PubMed ID: 2478001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M; Kotake T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
    Nishio Y; Shirahase T; Shichiri Y; Habuchi T; Matsuda T; Nishimura K; Hida S; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
    Pfeffer MR; Sulkes A; Biran S
    Isr J Med Sci; 1988; 24(9-10):599-603. PubMed ID: 3204008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination chemotherapy (BEAM regimen) for head and neck cancer].
    Noguchi A; Inoue A; Kasai N; Uchida M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2158-62. PubMed ID: 6194755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CDDP-containing combination chemotherapy for advanced lung cancer].
    Asamoto H; Hisa T; Sawano T; Sakai K; Kitamura S; Matsushita N; Kokura M; Satake H; Kawakami I
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract.
    Levi JA; Aroney RS; Dalley DN
    Cancer Treat Rep; 1980; 64(8-9):1011-3. PubMed ID: 6160912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.